CREBBP and medulloblastoma: Hereto, we performed knockdown of either CREB1, CREBBP, or EP300 in MED8A cells, an in vitro model for Group 3 medulloblastoma (Fig. 2e) and subsequently determined their sensitivity to the chemotherapeutic agent Etoposide.